You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 10, March 9, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Pulmonary Diseases, Other
 •Alert me on articles by topic

Brief Report: Respiratory Syncytial Virus Activity—United States, 2003-2004

JAMA. 2005;293:1186.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2004;53:1159-1160

1 figure omitted

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections (LRTIs) (i.e., bronchiolitis and pneumonia) among young children, resulting in an estimated 51,000-82,000 hospitalizations annually.1 RSV causes severe disease among older adults and persons of all ages with compromised respiratory, cardiac, or immune systems, and can exacerbate chronic cardiac and pulmonary conditions.1,2 3,4 In temperate climates, RSV infections occur primarily during annual winter season outbreaks. This report summarizes trends in RSV activity reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) during July 2003–June 2004 and presents preliminary data from the weeks ending July 3–December 4, 2004, indicating the onset of the 2004-05 RSV season. Health-care providers should consider RSV in the differential diagnosis for persons of all ages with LRTIs, implement appropriate isolation precautions to prevent nosocomial transmission,5 and provide appropriate immune prophylaxis to eligible children, including certain premature infants . . . [Full Text of this Article]

Reported by:







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.